CRO & Vendor Selection: Immuno-Oncology Phase IB/II Study
We helped our client to choose the best-fit CRO for their clinical study through an evidence based decision-making process.
Company Type: Global Biotech
Company Size: large enterprise
Location: HQ in the U.S., operating world wide
Therapeutic Area: immunology and oncology
After experiencing unrealized expectations with a CRO, our client at a global biotechnology asked us to help him and his team to conduct a CRO market analysis and a RFP process for an Immuno-oncology clinical trial.
Our evidence based decision making process allowed their team to choose a CRO whom they were finally satisfied.
“Seuss+ was more than 100% engaged in setting up a very professional vendor selection process. The thorough preparation based upon a very pleasant collaborative interaction and good understanding of the clinical operational field as well as a rigid follow-up during the process resulted in a strong evidence-based decision for selecting the final vendor.”
Chief Medical Officer
Four steps to selecting the best-fit CRO
Step 1 – Key selection criteria, desired CRO capabilities framework, and clinical trial team alignment
Step 2 – CRO global capabilities market analysis
Step 3 – CRO selection, including RFP process and bid defense meetings
Step 4 – RFP contract negotiations
A new solid partnership
- Satisfaction improvement with the CRO selection, reversing the previous bad experience
- Alignment of the new clinical team
- Minimization of scope changes due to a diligent RFP
- Significant discount as a result of contract negotiations
Do you need help with your clinical program?
We‘d love to get to know you and your business. We are ready to answer your questions and start tackling your business challenges.